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Human graft-versus-host disease (GVHD) has several 
cutaneous manifestations, including a lichenoid and a 
sclerotic injury pattern. A versatile animal model of 
graft-versus-host skin disease (GVHSD) would facilitate 
study of the pathophysiology of these two cutaneous 
injury patterns. We have examined two murine .chi-
meras histologically and have found two distinct pat-
terns. Allogeneically transplanted Bl/6 mice show a 
prolonged lichenoid-interface dermatitis that eventu-
ates in clinical alopecia, whereas LP/J recipients of 
allogeneic cells do not show hair loss. Their histopath-
ology consists of an early lichenoid phase that abates 
and is replaced by dermal sclerosis. Because of the ver-
satility of the mouse as a laboratory animal, we feel that 
this model provides an excellent opportunity to define 
the immunopathologic mechanisms responsible for skin 
injury in GVHD. In addition, an understanding of the 
pathogenesis of the T cell-dependent, lichenoid, and 
sclerotic patterns of tissue injury in GVHSD might well 
provide insight into the pathogenesis of the GVHSD 
analogs, cutaneous lupus erythematosus and sclero-
derma. 
The skin is a major target organ in both the acute and 
chronic phases of human graft-versus-host disease (GVHD), 
yet litt le is known about the pathophysiology of the cutaneous 
injury (1] . A versatile animal mode of acute and chronic graft-
versus-host skin disease (GVHSD) would allow investigation 
of the immunologic mechanisms involved. In 1963 Stastny et 
al [2] described a rat model of GVHD in which there was both 
acute and chronic cutaneous involvement. However, the rat 
model has not been used to further define the mechanisms 
responsible for the interesting patterns of injury that develop 
in the skin. 
It is still widely thought that the mouse only rarely expresses 
GVHD in the skin [3]. However, van Bekkum showed in 1959 
that murine GVH can involve the skin [4] and Rapapport et al 
[5] have confirmed that cutaneous involvement is a consistent 
finding. The mouse offers several advantages over the rat and 
other laboratory animals since it is better defined genetically 
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and immunologically. The purpose of this report is to contrast 
t he histologic changes of GVHSD that occur in 2 murine 
chimeras: LP/J---+C57B1/6J[B1/6] and the reverse, B1/6---+LP/ 
J. Allogeneically transplanted B1/6 mice (i.e., mice given ge-
netically disparate cells) show a progressive interface dermatit is 
that resembles some forms of cutaneous lupus erythematosus 
(LE) and that eventuates in alopecia. LP I J recipients of allo-
geneic cells do not develop hair loss. The histopathologic 
changes in this chimera are biphasic with an early epidermal-
dermal interface dermatitis that resembles some forms of cu-
taneous LE, and a later sclerosis that resembles scleroderma. 
MATERIALS AND METHODS 
Mice \ 
Female C57BL/6J and LP/J mice were purchased from the Jackson 
Laboratory, Bar Harbor, Maine. Both strains are H -2b and mutually 
nonreactive in mixed lymphocyte culture, but differ at multiple minor 
histocompatibility loci [6]. Donor and recipient mice were 7- 15 weeks 
old at the time of transplantation. 
A ntisera 
Monoclonal anti-Thy 1.2 (asc ites fluid from clone H0-13-4 of Mar-
shak-Rothstein eta] [7] was tested with guinea pig complement for 
specific T -cell lytic effect. It was found to prevent T -cell proliferation 
to phytohemagglutinin and concanavalin A, but did not alter B-cell 
proliferation to lipopolysaccharide. 
Cell Suspensions 
Bone marrow was obtained by flushing the marrow cavities of the 
femurs and tibias of donor animals with cold Hanks' balanced salt 
solution (HBSS) conta ining heparin (2 units/ml), penici ll in (50 units/ 
ml) , and streptomycin (50 llg/ml). Clumps were disrupted by gently 
flu shing the marrow several times through an 18-gauge needle. The 
bone marrow cells were then washed in cold HBSS and the number of 
nucleated, viable cells determined by trypan blue exclusion. 
Sp leen cell suspensions were obtained by mechanically teasing apart 
the spleen in cold HBSS after the red blood cells had been lysed with 
Tris-ammonium chloride. The spleen cells were then washed in cold 
HBSS and the number of nucleated, viable cells determined by trypan 
blue exclusion . 
T-Cell Depletion of Donor Cell Inoculum 
D onor T cells were removed from the inoculum, as one of the control 
conditions, by incubation with anti-Thy 1.2 antibody at o· for 15 min 
at a final di lution of 1:100 followed by the addition of .guinea pig 
complement (Pel-Freeze) at a final di lution of 1:4. The cells were then 
incubated at 37"C for 30 min, washed 3 times in HBSS, and counted. 
Transplantation 
Recipient mice were given neomycin (50 llg/ml) and polymyxin B 
sulfate (50 llg/ ml) in their drinking water starting 2 days before 
transplant and continuously thereafter. Recipient mice were then given 
a lethal dose (950 R) of gamma radiation from opposing '37Cesium 
sources (Gammacell 40, Atomic Energy of Canada, Ltd.) at a dose rate 
of 95 rads/min . Each recipient was given 2 x 107 viable donor bone 
marrow and 5 X 107 donor spleen cells in a single 0.5-ml tail vein 
injection. LP!J and C57Bl/6J animals were alternately used as donors 
and recipients. 
Controls consisted of (1) mice transplanted with syngeneic bone 
marrow and spleen cells (i.e., cells from the same, genetically identical 
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stra in), (2) mice transplanted with T cell -depleted allogeneic bone 
marrow and spleen cells. 
Test for Chimerism 
This transplantation procedure has been tested for recipient chimer-
is m using a microcytotoxicity assay [8]. The actua l mice used in the 
present experiments were sampled for chimerism by hemoglobin elec-
t rophoresis. All mice tested had donor, as well as some residua l recipient 
hemoglobin at 34 days after tra nsplantation. 
Histology 
Skin specimens were routinely obtained from the abdomen. T he 
t issue was fixed wi th 10% buffered formalin and processed for light 
microscopy. Slides were stained with hematoxylin a nd eosin (H & E) 
a nd acidified to luidine blue. 
B linded Histopathology Analysis 
A dermatopathologist (J.B .) examined 57 coded and random ly num-
bered H & E stained slides from: syngeneic controls, T cell -depleted 
cont rols, norma l mice, LP/ J->C57BL/6J chimeras, and C578 1/6J-> 
L P /J chimeras, taken at various t imes after t ransplantation. Each of 
27 criteria (Table I) was graded on a 0- 4+ scale of increasing severity 
w it h 0 representing no discernable difference from normal skin a nd 4+ 
represent ing the most severe change noted in the group. Epidermal and 
d erma l t hickness were measured by an ocular micrometer. 
Blinded Direct Immunofluorescence Analysis 
Lip a nd/or abdominal biopsies were p laced in O.C.T. compound (Lab 
Tek Products) and snap-frozen in liquid ni t rogen. Four-micron sections 
were then stained wi t h fluoresceinated goat antimouse IgG, IgA, and 
lgM ("whole gamma"). Biopsies were read by 2 experienced observers, 
without knowledge of t he source. 
RESULTS 
Incidence of Histologic GVHSD 
The incidence of histologic GVHSD is dependent on the 
spleen cell dose. In t his study (5 X 107 nucleated spleen cells 
per recipient), all but one of t he allogeneically transplanted 
mice developed a lethal GVHD and histologic skin involvement 
(29 out of 30 mice examined, or 97 %). Controls were of two 
t ypes: (1) recipient mice that were treated in all ways like their 
counterparts except t hat t hey were t ransplanted with syngeneic 
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bone marrow and spleen cells (7 mice examined); (2) recipient 
mice t hat were transplanted wit h allogeneic bone marrow and 
spleen cells that had been pret reated with anti-Thy 1.2 antibody 
and complement (5 mice examined). None of the controls 
developed GVHSD (Fig 1). 
F IG l. Micrograph of skin from a syngeneically t ra nsplanted LP / J 
mouse. Normal mouse abdomina l epidermis lacks melanocytes, has 
only 1- 2 nucleated cell layers, a nd lacks a gra nular layer. The derm is 
has no papillary division. x 125 . 
TABLE I. Severity of individual histopathologic features of murine graft-versus-host skin disease (GVHSD) 
Epidermis< 
Acanthosisd 
Colloid bodies 
Hyperkeratosis 
Liquefact ion degeneration 
Dermis' 
Density of lymphohistiocytic infiltrate 
Sclerosis 
Subcutis" 
Density of lymphohistiocytic infi ltrate 
Pi losebaceous uni ts" 
LP/ J-+B l /6 
(5 m ice) 
22 ± 13 
1-2+ " 
1-2+ 
1- 3+ 
1- 2+ 
1+ 
1- 2+ 
Early" 
Bl /6-+LP/ J 
(9 mice ) 
19 ± 11 
1-2+ 
1- 3+ 
1- 3+ 
1+ 
0- 2+ 
0- 2+ 
Atrophy 0- 1+ 0- 1+ 
Follicular plugging 1- 2+ 0- 3+ 
Liquefaction degeneration 1- 2+ 0- 3+ 
• Early GVHSD for LP/ J->Bl/6 chimeras, 12- 26 days; for Bl/6->LP/ J chimeras, 7- 14 days. 
b Late GVHSD for LP /J->81/6 chimeras, 27-40 days; for 81/6->LP/J chimeras, 15-28 days. 
LP/J-.Bl/ 6 
(5 mi ce) 
40 ± 11 
3-4+ 
3-4+ 
3-4+ 
3+ 
0 
3+ 
0- 1+ 
3- 4+ 
3-4+ 
Late• 
Bl /6-+LP/ J 
(10 mice) 
15 ± 7 
0 
1+ 
0- 1+ 
0- 1+ 
3-4+ 
0 
2- 4+ 
0- 1+ 
0- 1+ 
<Pathologic features looked for , but only rarely found, include: atrophy, edema, para keratosis, and satelli te ce ll necrosis. Subepidermal 
basement membrane zone thicken ing did not occur. 
d Expressed as mean number of microns ± 1 SD. Normal and control mice had an epidermal t hickness of 10 p.m . 
" A scale of 0-4+ was used (1 + = minimal, 4+ = maximal). Both contro l groups were uniformly graded 0 on all criteria. 
1 P lasma cells, neutrophils and eosinophils were not seen. Neither were perivascula r basement membra ne thickening, subepidermal edema, or 
red blood cell extravasation observed. Vascular di latation a nd myxoid degeneration were present only rarely. Dermal t hickness increased equally 
in both strains from an initial mean (± 1 SD) of 100 (± 20) p.m to 200 (±55) p.m. 
"Fat necros is was only an occasional findin g. 
"Periappendageal basement membrane th ickening did not occur. 
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LPIJ---+Bll6 Chimeras Lived Longer after Transplantation 
that BII6---+LPIJ Chimeras 
Twenty of 31 LP IJ---+B1I6 mice (65%) lived longer than 3 
weeks and 5 (16 %) survived 6 weeks. In contrast, of the 42 
B1I6---+LPIJ chimeras, only 5 (12 %) lived past 3 weeks and 
only 1 (2%) survived 4 weeks. The controls have had a normal 
survival rate for 1 year of observation. 
Alopecia Occurs Late in the Course of GVHSD in the 
LPIJ---+Bll6 Chimeras and Not At All in the Bli6---+LPIJ 
Chimeras 
Although the onset of the histologic change of GVHSD was 
day 12 ± 2 in the LP /J---+B116 chimeras, alopecia was not noted 
unt il 4 weeks after transplantation. It then developed in a 
characteristic pattern starting on the nape of the neck and 
spreading to involve the face, upper back, and inner forelegs. 
Later the abdomen and midback became involved. Marked 
scale and focal erosions were revealed by the hair loss (Fig 2). 
Subtle scale had been seen on the abdomens when shaved for 
biopsy at 3 weeks (disease duration, 9 ± 2 days). 
The B116---+LPIJ chimeras did not develop hair loss. Scale 
was noted on their shaved abdomens after the second week 
(disease duration, 7 ± 2 days) . 
Histopathologic Sequence of LP IJ---+Bl 16 GVHSD 
Fig 3 illustrates the evolution of the cutaneous pathology in 
t he LP I J---+B 116 chimeras. The acute injury pattern in the 
epidermis and follicu lar epithelium occurred together and in-
cluded (grade 2+) basal layer liquefaction degeneration, mono-
nuclear cell exocytosis, and individual cell necrosis (with oc-
casional satellite cell necrosis). (Fig 4). The dermis and subcutis 
developed a round cell infiltrate in parallel with the epidermal 
injury. These changes were focal at first, and then became 
widespread. Later epidermal changes included hyperkeratosis, 
acanthosis, and the appearanc~ of a granular layer. Follicular 
plugging paralleled the epidermal hyperkeratosis (Fig 5). 
The intensity of the epidermal injury and the mononuclear 
FIG 2. Alopecia in an LP/J-->Bl/6 chimera 35 days after transplan-
tation. Scale is present in the ears as well as over the snout. Focal 
erosions are also present. 
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cell infiltrate in the dermis and subcutis progressively increased 
(3-4+) during the course of the reaction. The dermal mast 
cells, as assessed by toluidine blue staining, appeared partially 
degranu lated, but not absent. A mild dermal sclerosis was seen 
only between days 20- 25 (1- 2+ ). Dermal thickness progres-
sively increased in parallel with the intensity of inflammation. 
In an effort to correlate the clinical alopecia with the histology, 
we obtained 3 simultaneous biopsies from mice with loose hair 
on the nape of the neck, but normal-appearing, firmly rooted 
hair on the lower back and abdomen. The histology at all 3 
sites was identical. 
In summary, LP I J---+B 116 chimeras develop a mononuclear 
cell infiltrate with epidermal and follicular injury that persists 
and intensifies for the life of the mouse. There was no signifi-
cant sclerosis . Alopecia was not evident until 2 weeks after the 
histologic onset of GVHSD. 
Histopathologic Sequence of Bli6---+LPIJ GVHSD 
Fig 3 illustrates the temporal sequence of the biphasic 
GVHSD seen in B116---+LP IJ chimeras. The early changes were 
similar to those in the reciprocal chimera (LP IJ---+B116) in 
having epidermal and follicu lar basal layer liquefaction degen-
eration , mononuclear exocytosis, individual cell necrosis, and 
occasional satelli te cell necrosis. The ensuing epidermal acan-
thosis and hyperkeratosis, follicular plugging, and dermal infil-
trate were also similar. The only differences were an earlier 
onset of GVHSD (7 vs 12 days) and a complete loss of mast 
cell metachromatic staining, occuring on day 12 ± 2. 
The B1I6---+LP IJ GVHSD then underwent a histologic trans-
formation, beginning at about 14 days. The dermal infiltrate 
abated, the dermis and subcutis became sclerotic, and the 
pi losebaceous units were compressed and markedly atrophic. 
The epidermis returned to normal, as the sclerosis became 
more dense (3- 4+), and the dermis thickened (Fig 6) . In sum-
mary, the B116---+LP IJ chimeras had a biphasic GVHSD. An 
early lichenoid-interface phase, wh ich was similar to the early 
phase of the LP I J---+B 116 chimeras, was replaced by a dense 
sclerosis. The duration of the epidermal and fo llicular injury 
was 10 days, in contrast to 30 days for the LPIJ---+B1I6 chi-
meras. 
Extracutaneous GVHD 
The parotid and submandibular (but not the sublingual) 
glands in the allogeneically transplanted LP jJ mice progres-
sively developed a round cell infiltrate, acinar destruction, and 
periductal fibrosis. Neither the control mice nor the LP /J---+ 
Bll6 chimeras had abnormal salivary glands. 
Both chimeras had liver involvement (a periportal, mono-
nuclear cell infiltrate) and both had an interstitial round cell 
infiltrate in the lungs and kidneys. The lymphoid organs be-
came markedly atrophic. The thyroid, pancreas, and adrenal 
glands appeared normal, as did the small and large intest ines. 
Immunoglobulin Deposition in the Basement Membrane Zone 
Is Seen Equally in Allogeneically and Syngeneically 
Transplanted Mice 
Linear basement membrane zone (BMZ) immunoglobulin 
deposition was found in LP IJ---+B1I6 chimeras in 3 out of 14 
mice examined (21 %) and in 1 out of 4 syngeneically trans-
planted B1I6---+B116 controls (25 %). The positives occurred at 
9 and 10 days in the allogeneically transplanted mice and at 13 
days in the one positive syngeneic control. 
In the B 116-------+LP I J chimeras there was no BMZ immuno-
globulin deposition in either the early-lichenoid, or late-scler-
otic phase of GVHSD (8 mice examined). One of 4 syngeneic 
controls (LPIJ---+LPIJ) was positive at 21 days. 
DISCUSSION 
The cutaneous manifestations of murine GVHD have been 
neglected in the past, perhaps because of the paucity of gross 
changes, including the absence of cutaneous erythema and the 
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FIG 3. Histopathologic sequence of 
GVHSD in allogeneically t ra nsplanted 
mice. Bl/6--->LP /J chimeras are repre-
sented by solid bars; LP /J--->Bl/6 chi-
meras by hatched bars. (A) The onset of 
histopathologic features varied a mong 
t he mice for t he same, or repeat, experi-
ments by as much as 4 days (± 2). (B) 
The cessation of liquefaction degenera-
t ion in B1/6--->LP /J chimeras varied by · 
8 days(± 4). (C) Occasional satellite cell 
necrosis was also seen (i.e., mononuclear 
cell cont iguous with an apoptotic epider-
mal cell). (D) In contrast to t he B1/6---> 
LP /J chimeras, where t here was a n ab-
sence of cells staining metachromatically 
w it h to luidine blue, t he LP /J->B1/6 
mice had mast cells, but they had fewer 
stainable granules/cells. (E) Sclerosis in 
t he B1/6 recipients was mild (1 - 2+) and 
transient. (F) Sclerosis was not seen in 
t he subcut is of t he Bl/6 recipients. (G) 
No B1/6--->LP /J chimera survived longer 
than 28 days afte r t ranspla ntation. (H ) 
No LP /J--->B l /6 chimera survived longe r 
t ha n 40 days. 
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FIG 4. Micrograph of the ea rly changes in skin from a n LP /J--->Bl/ 
6 chimera. The early in terface dermatitis seen in murine GVHSD has 
basal layer liquefaction , round ce ll exocytosis, and individual ce ll 
necrosis. The dermis has a diffuse round cell infiltrate. x 125. Inset, 
Satelli te ce ll necrosis. This higher-power micrograph shows satellite 
ce ll necrosis (a.ITOW). x 1000. 
variability of alopecia. Argenbright and Forbes [9] recently 
examined the inflammatory reaction in mice produced by an-
thracine skin painting followed by UV A exposure. Although 
they found a 9-fold increase in cutaneous blood content, cuta-
t(G) ~(H) 
0~--~7~--~1~4~--~2~1----~28~--~3~5~~40 
DAYS AFTER TRANSPLANTATION 
neous erythema was not observed. The same condit ions, how-
ever, produced cutaneous erythema in pig skin with only a 2-
fold increase in blood content. They attributed the absence of 
expected erythema in the mice to t he fact t hat a papillary 
arcade of capillary loops is not found in murine skin. Therefore, 
cutaneous erythema cannot be used to detect the early phases 
of murine GVHSD as it can in human GVHSD [10,11]. Alo-
pecia develops in 1 of the 2 chimeras (LP IJ--->B116) and then 
only as a late manifestation , i.e., 2-3 weeks after the histologic 
onset of GVHSD. The definite head-to-tail sequence of the 
alopecia follows the same order as the normal wave of anagen 
hair growth in the mouse. Since the duration and intensity of 
the follicular injury are similar in areas with alopecia and 
without, t he hair loss per se is probably due to programmed 
loosening of hair without normal replacement. That the 
B116--->LP IJ chimeras fa il to develop alopecia may be due to 
the relatively mild and short- lived follicular injury. 
We have described 2 mouse models for human GVHSD: the 
LP IJ--->B1I6 chimeras develop an interface dermatitis involving 
the epidermis and fo llicles as in acute human GVHSD [12-14] 
t hat persists and intensifies, while the B1I6--->LP /J chimeras 
show a biphasic course, with an early lichenoid and a later 
sclerotic phase, as in late chronic human GVHSD [15]. Al-
though the pathologic patterns differed, dermal thickness in-
creased in both chimeras. The increase was due to inflammation 
in t he one instance (LP I J---.B 116) and sclerosis in t he other 
(B 116--->LP I J). 
Acute and chronic human GVHSD have long been recognized 
as mimicking severa l spontaneously occurring human diseases 
t hat have features of autoimmunity. In t he skin , acute human 
GVHD most often displays t he clinical appearance of a non-
specific exanthem, cutaneous LE, or in severe cases, toxic 
epidermal necrolysis; whereas, chronic human GVHD often 
resembles lichen planus, discoid LE, scleroderma, lichen 
sclerosis et atrophicus, lupus profundus, or poikiloderma [16-
20]. In assessing some of t he early human bone marrow trans-
plant patients with GVHSD, Hood et al even considered the 
possibility that t he patients had underlying or coexistent cu-
taneous LE and scleroderma [11] . Stastny et al [2] specifically 
416 CHARLEY ET AL 
FIG 5. Micrograph of the later epidermal and follicular changes in 
the LP/J-->Bl/6 chimera (28 days) . Hyperkeratosis, follicular plugging, 
acanthosis and the appearance of a granular layer are now found in 
addition to the previous, persistent acute changes. x 200. 
FIG 6. Micrograph of the sclerosis seen in the late phase of Bl/6--> 
LP/J GVHSD (28 days). A dense sclerosis is present. The follicles are 
compressed and atrophic. Sebaceous glands have disappeared. x 125. 
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noted the similarity of the histopathologic changes in his rat 
model to cutaneous LE and scleroderma. Like acute GVHSD, 
the acute and subacute subsets of cutaneous LE have a rela-
tively cell-poor lichenoid injury pattern, in which individual 
cell necrosis can be seen [12,21,22]. The interface dermatitis 
that occurred in both of the murine chimeras is also closest to 
the acute and subacute subsets of cutaneous LE. Specifically, 
the BMZ thickening that occurs in discoid LE was not seen. 
Although the mechanisms responsible for the basal layer injury 
in cutaneous LE are debated [23,24], the fact that GVHSD is 
T cell-dependent and probably T cell -mediated [3) strengthens 
the concept of cell-mediated injury in LE skin disease [25]. 
Although there are interesting similarities, the late phase of 
human chronic GVHSD and the sclerosis of murine GVHSD 
do differ from each other and from human scleroderma in some 
respects. In contrast to human scleroderma, where early scler-
otic changes are seen in the deep dermis, chronic human 
GVHSD shows a sequential dermal sclerosis beginning in the 
upper dermis followed by changes in the deeper dermis [26]. 
The mouse model described in this report has not shown a 
similar differential onset of sclerosis within the dermis on 
routine light microscopic examination. This might be related 
to the fact that the mouse dermis lacks a division into papil-
lary and reticular portions. In spite of this difference, the 
B1/6~LP /J model offers an opportunity to study a T cell-
dependent dermal sclerosing reaction that might give insight 
into the pathogenesis of human scleroderma. 
Sullivan et al recently reported that more severe acute human 
GVHSD was a risk factor for developing chronic GVHSD 
[27). While a few patients develop chronic GVHSD de novo 
(i.e., without an acute phase) , or following a symptom-free 
interval after acute GVHSD, the majority of patients have 
progressive GVHSD, with a continuum from acute to chronic 
GVHSD [12,28]. Our murine model most closely parallels this 
latter course in that we have never observed the sclerotic 
changes without antecedant acute GVHSD in B1/6~LP/J 
chimeras. A better understanding of the reasons why LP !J~ 
B1/6 chimeras have only a mild transient sclerotic phase may 
help clarify the relationship between the acute and chronic 
forms of human GVHSD. 
Mast cells have been reported to be degranulated in the early 
phase [14] and late sclerotic phase [29] of human GVHSD: Our 
finding intact mast cells by toluidine blue staining while the 
mononuclear cell infiltrate is developing (days 7-11) in the 
Bl/6~LP /J chimeras with a subsequent loss of toluidine blue 
staining (days 12-15) suggests a reactive rather than a primary 
role for mast cells. Preliminary electron microscopic studies of 
the Bl/6~LP/J chimeras also show an absence of mast cells 
in the later stages. In contrast, the LP /J~B1/6 chimeras do 
not have a complete loss of mast cell. They also do not show a 
cessation of the epiderma1 and dermal inflammatory reaction, 
and do not have significant sclerosis. Perhaps the mechanism 
of sclerosis in the Bl/6~LP /J GVHSD is related to the factors 
that terminate the cellular inflammatory component and that 
result in a loss of mast cells. 
Immunoglobulin at the dermal-epidermal junction has been 
reported in both acute and chronic human GVHSD [30,31] ; 
however, on ly a minority of acute GVHSD patients have had a 
staining score higher than controls. 
We looked at both lip and abdominal sites because of regional 
variation in subepidermal immunoglobulin deposition in mice 
[32]. Although the numbers of mice examined are small, the 
finding of an equal incidence of immunoglobulin deposition in 
mice with and without histopathologic skin disease suggests 
that it is playing no pathologic role. There are several other 
murine examples of immunoglobulin deposition in the skin 
without cutaneous damage [33,34). 
In summary, we have compared and contrasted two histo-
pathologic patterns of murine GVHSD. Allogeneically trans-
planted Bl/6 mice show a prolonged lichenoid-interface der-
matitis that eventuates in clinical alopecia, whereas LP /J re-
Nov. 1983 
cipients of allogeneic cells do not show hair loss. T heir histo-
pathology consists of an early lichenoid phase that abates and 
is replaced by dermal sclerosis. 
Because of t he versatility of the mouse as a laboratory animal, 
we feel that this "model provides an excellent opportunity to 
define the immunopathologic mechanisms responsible for skin 
injury in GVHD. In addit ion, understanding of the pathogen-
es is of the T cell-dependent, lichenoid and sclerotic patterns of 
tissue injury in GVHSD might well provide insight into the 
pathogenesis of t he GVHSD analogs, cutaneous LE and scle-
roderma. 
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